OH, East is East and West is West and never the twain shall meet.
Nice verse, but unacceptable R&D policy.
This morning the NEJM published "Asia's Ascent: Global Trends in Biomedical R&D Expenditures."
Co-authored by Steve Sammut, Senior Fellow, Health Care Management Lecturer, Entrepreneurial Programs Wharton School, University of Pennsylvania, and board member at the Center for Medicine in the Public Interest, the article provides data to support the positions of Francis Collins and others that the US contribution to research is rapidly eroding relative to other countries, particularly in East Asia.
In recent years, industry has reduced its investment in U.S. biomedical research and development by billions of dollars, while increasing investment in Asia–Oceania. Thus, boosting U.S. government funding alone may be inadequate for retaining long-term R&D leadership.
Francis Collins is sending the article to Congress
Attention must be paid.
